{"published": "2015-09-30T19:36:09Z", "media-type": "News", "title": "Celldex Therapeutics to Present at the Leerink Partners Immuno-Oncology Roundtable", "id": "915965d6-98fa-4b4a-ab27-3c843050c343", "content": "HAMPTON, N.J., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony Marucci, Co-founder, President and Chief Executive Officer, and Thomas Davis, M.D., Executive Vice President and Chief Medical Officer, will participate in a fireside chat at the Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015 at 1:05 p.m. EDT in New York City. \n\nThe live webcast of the presentation will be available on the \"Events & Presentations\" page of the \"Investors & Media\" section of the Celldex website. A replay of the presentation will be available for seven days following the event. \n\nAbout Celldex Therapeutics, Inc. \n\nCelldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \n\nCONTACT: Sarah Cavanaugh, Vice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 scavanaugh@celldex.com \n\n\u00a9 2015 Canjex Publishing Ltd. All rights reserved.", "source": "Stockwatch"}